Supplementary text (for Figure S1):
From the predicted size of the BGIN doublet produced from constructs comprising the 5' UTR, a larger BGIN product was initiating from a codon upstream of the peptide identified ( Figure 1B) , while a smaller BGIN product was initiating approximately 200 nts downstream (producing an isoform ~8 kDa smaller). Two non-ATG start codons resided upstream of the BGIN N-terminal peptide identified, a Val (GTG) and Leu (CTG) codon. Mutagenesis of the Val (V13, Figure S1C ) had no effect on expression of the doublet, while mutagenesis of the Leu (L1R) resulted in deletion of the larger BGIN isoform ( Figure S1C , black arrow). Constructs initiating from the L1 through a L1M mutation produced a band matching the larger doublet band in wild-type BGIN ( Figure S1C , black arrow).
The first ATG encountered downstream of the CTG initiation site was M73, which provided an ideal candidate downstream initiation site to produce a BGIN isoform ~8 kDa smaller in relation to the L1 initiated full-length product. To test this, we expressed a construct initiating at the first in-frame Met (M73, M73-Start) and compared its size to wild-type, and L1 initiating constructs ( Figure S1E ). As expected, constructs initiating at this downstream ATG corresponded to the lower BGIN doublet. Moreover, cumulative mutation of the downstream methionines in the BGIN ORF shifted the lower doublet band to progressively smaller sizes (Figures S1E, S1F), demonstrating that the initiation of this smaller doublet band is a product of ATG initiation downstream of the CTG initiator signal. This indicates that excision of the 2 nd 3BP1 BAR exon recodes the first 42 aa's within the BGIN BAR domain, and initiation of BGIN at the CTG initiator produces a full-length product of 677 aa with a predicted molecular weight of 73.59 kDa.
The smaller BGIN form which initiates from the first in-frame ATG is predicted to be 605 aa with a molecular weight of 66.19 kDa.
As mentioned in the main text, only the larger ~74 kDa isoform is observed in brain, indicating that BGIN initiation primarily utilizes the CTG (L1) codon identified. Glutathione sepharose precipitates were immunoblotted for GST or GFP as indicated. CIN exon 2 allele with single residue reversions to wild-type residues as indicated. GST proteins were precipitated with glutathione sepharose and immunoblotted for GST or Ub.
(F) Reversion of two mutational clusters, R602C/V603I and P637L/P39L in the mut159 allele were assayed for poly-Ub recoupling as described in (E). The P637/639L reversion RNAi) or 2 rounds over 4 days (long-term RNAi). Cells were then harvested and subjected to Rac1-GTP detection by PBD pulldown assay.
Supplemental Methods

Plasmid constructs
pGEX4T3 vectors comprising NEMO and Abin1 UBAN motifs or the hRad23A UBA1 domain were a generous gift from Dr. Ivan Dikic (Goethe University Frankfurt).
pGEX6-MUD1 was generously received from Dr. David Komander (MRC, UK).
Fragments comprising these Ub-binding components were also cloned in-frame and 3' of the GST tag for expression in mammalian cells in the pRK5mGST vector.
Plasmid constructs, and generating stable cell lines.
The original AK126873 cDNA clone (clone ID no. BRAMY3014613) was purchased from the National Institute of Technology and Evaluation (NITE, Japan), and the SH3BP1 (3BP1) clone was obtained from the Sanger Institute (UK). All BGIN PCRbased site-directed mutagenesis and PCR-generated BGIN fragments required 5% DMSO, and all PCR fragments produced for subcloning were generated using Pfu Turbo polymerase (Stratagene, Santa Clara CA).
BGIN constructs were initially generated with C-terminal GST or GFP tags inframe with the BGIN ORF in pCDNA3, which includes the intact 5' BGIN UTR. In order to identify the 5' translation start site in BGIN, the BGIN N-terminal BAR domain (5'UTR comprising 211 nt's upstream of the BGIN 1-262 region) was cloned in-frame with a C-terminal GST tag (pCDNA3 5'UTR/BAR-GST), purification of this BAR fragment yielded N-terminal BGIN sequence information described in Results.
pTRChis 6 Ub2-Ub5 and pGEX4T3 Ub -Ub7 constructs were cloned by serially inserting Ub monomer units with BamH1/Sal1 ends 5' upstream of an anchoring Ub unit (containing a stop codon) using BamH1/Xho1 sites generated using PCR oligos.
Antibody purification
Antibodies specifically recognizing the BGIN 574-677 region were affinity purified from rabbit antisera from rabbits immunized with the full-length CIN antigen:
recombinant GST-BGIN 574-677 was immobilized on CNBr-Sepharose and immunoreactive antibodies were bound and eluted as described previously (Gohla et al., 2005) . Antibodies recognizing the unique BGIN 1-42 N-terminal region were affinity purified from rabbits immunized with his 6 -tagged recombinant BGIN , and antibodies specifically recognizing this unique N-terminal epitope were collected by binding the rabbit antisera to GST-tagged BGIN 1-42 crosslinked to glutathione sepharose (GE Healthcare, Piscataway NJ). Antibodies were eluted with 0.1M Glycine pH 2.5, and dialyzed in 1x PBS/5% glycerol.
Protein purification
Purification of the BAR-GST fragment used for sequence determination of the BGIN N-terminus was performed by glutathione-sepharose precipitation from HeLa cell lysates in 1%NP40/Hepes buffer 1 (20mM Hepes pH 7.5, 150mM NaCl, 10mM MgCl 2 , 5% glycerol) expressing 5'UTR/BAR-GST using the pCDNA3 construct described above.
Beads were washed in Hepes buffer 1 and eluted in 30mM reduced glutathione in buffer A (20mM Hepes/0.5M NaCl), and dialyzed in Hepes buffer 1. Proteins were then TCA precipitated in 100% TCA, washed in acetone, dried and submitted for analysis by mass spectrometry. A portion of the precipitated sample was retained for silver staining.
For purification of BGIN-HAhis 6 complexes for mass spectrometry analysis, ten 150mm dishes of HeLa cells were transfected with pCDNA BGIN-HAhis 6 (complete with 5' UTR), and cells were lysed in 11mls of Hepes buffer 1 (20mM Hepes pH 7.5, 150mM NaCl, 10mM MgCl 2 , 5% glycerol) with 1% NP40 were collected ~16h following transfection. Imidazole was added to 10mM and His 6 -tagged proteins were precipitated using 2.5mls of Ni-NTA agarose (50% slurry). Beads were then washed twice with 25mls of lysis buffer with 1/% NP40/25mM imidazole, and twice with 25mls of buffer without detergent. Proteins were eluted with 300mM imidazole in Buffer A (20mM Hepes pH 8, 0.5M NaCl), dialyzed in detergent-free lysis buffer and concentrated 10-fold using an Amicon-15 filter.
Recombinant his 6 -GST-tagged CIN exon2 expressed using pTRC (in BL21 E.
coli) was solubilized from inclusion bodies by sonication in urea buffer (8M urea, 20mM
Hepes pH 8.0, 100mM NaCl), and bound to Ni-NTA beads in 10mM imidazole. After two washes in urea buffer/and two washes in 1x PBS each in 20mM imidazole, bound proteins were renatured in 0.3M NDSB-201/1x PBS at 4°C for 0.5h, washed twice in 1x PBS and eluted in 0.3M imidazole/1x PBS. Proteins were dialyzed in 1x TBS/5% glycerol with 0.3mM DTT. Similarly, his 6 linear poly-Ub chains (Ub2 to Ub7) expressed using the pTRC vector was purified from BL21 E. coli lysed in native buffer (50mM Tris pH 7.5, 100mM NaCl, 5mM MgCl 2 , 1mM EDTA, 1mM DTT) and bound to Ni-NTA agarose in 10mM imidazole. Beads were washed in 20mM imidazole in buffer A, and eluted with 0.3M imidazole buffer A. Proteins were dialyzed in 1x TBS/5% glycerol/0.3mM DTT.
Recombinant GST, GST-RBD and GST-PBD were expressed from pGEX vectors in BL21, induced for 5h at 37°C (GST-RBD was induced at 30°C) and lysed in native buffer. GST proteins were bound to glutathione-sepharose, washed several times with buffer A and eluted in 30mM reduced glutathione in 0.3M Hepes pH 8.0. GST-PBD/GST-RBD was dialyzed in 25mM Tris pH 7.5, 1mM EDTA, 5mM MgCl 2 , 50mM
NaCl, 5% glycerol, 0.5mM DTT, and GST was dialyzed in 1x TBS/5% glycerol/0.3mM
DTT. 
In vitro pulldown assays for CIN exon 2/poly-Ub interactions
Proteomic analysis of CIN exon 2/poly-Ub chains
Four 10cm dishes of HeLa cells were transfected with the pRK5mGST empty vector, or pRK5mGST-CIN exon 2 plasmid construct and treated with 5µM MG132 for 5h, 16h post-transfection. Lysates were generated in Hepes buffer 1/1% NP40, and GST proteins were precipitated with 0.3mls glutathione sepharose slurry. Beads were washed 3 times with 15mls Hepes buffer 1/1%NP40 and eluted in 3.5mls 30mM reduced glutathione in 0.3M Hepes pH 8.0. Samples were dialyzed in 0.1M Tris-HCl pH 8.5
overnight and concentrated with an Amicon filter (10kDa cutoff) to a final protein concentration ranging from 3-5mg/ml. Samples were digested with trypsin and subjected to analysis by mass spectrometry as described below. Ubiquitin peptides comprising an additional lysine-conjugated di-glycine (GG) signature indicating poly-Ub chain conjugation were identified and mapped to specific lysines on the Ub peptide. Methods for mass spectrometric and bioinformatic analysis is described below.
Mass spectrometric analysis
Proteins were reduced with 5 mM Tris(2-carboxyethyl)phosphine hydrochloride (Sigma-Aldrich, St. Louis, MO, product C4706) and alkylated with 10 mM 2-chloroacetamide (Sigma-Aldrich, St. Louis, MO). Proteins were digested for 18 hr at 37 °C in 2 M urea 100 mM Tris pH 8.5, 1 mM CaCl2 with 2 ug trypsin (Promega, Madison, WI, product V5111) and digest reactions were terminated with formic acid (5% final concentration). Debris was removed by centrifugation, 30 min 18000 x g.
MudPIT microcolumn assembly, equilibration and experimental data acquisition was performed as described previously Wolters et al., 2001 ).
Protein and peptide identification was extracted from the raw spectral data as described previously (McDonald et al., 2004) . To identify poly-Ub chains in CIN exon 2 precipitates, a decoy database containing the reversed sequences of all the proteins appended to the target database was employed to accurately estimate peptide probabilities and false discovery rates (Peng et al., 2003) . Tandem mass spectra were matched to sequences using the ProLuCID algorithm with 50 ppm peptide mass tolerance. The search space included all fully tryptic peptide candidates that fell within the mass tolerance window with no miscleavage constraint. Carbamidomethylation (+57.02146
Da) of cysteine was considered as a static modification. Ubiquitination (+114.042927) of lysine was considered as a differential modification. in an equal volume of Opti-MEM prior to transfection. Transfected cells were incubated for 48h prior to harvest and processing for chemiluminescence assay for ROS generation (described below).
Serial siRNA treatment of SH-SY5Y cultures required initial seeding of 10 6 cells in 60mm dishes. Cells were transfected with 20nM siRNA oligos/4µls of RNAi Max into a shallow volume of serum-free media (1.6mls), where the total volume was added to 4mls after transfection. Cells were replated onto 60mm dishes for PBD pulldown assay (0.8 to 10 6 cells) or consequent transfection (10 6 cells) of siRNA (2x RNAi) 48 to 72h post-transfection depending on cell growth. This was repeated for a final round (3x RNAi) of transfection, where cell growth often became extremely slow after 3 rounds of siRNA transfection. PBD assay conditions for SH-SY5Y cells are described below.
PBD pulldown assays for Rac1/Cdc42 and RhoA-GTP measurements
Rac1-GTP levels were measured by PBD pulldown as described previously (Benard et al., 1999; Stofega et al., 2006) fractions (at least 500µg) was subjected to PBD assay as described above, or with recombinant GST-RBD (Rhothekin RhoA-binding domain) (Ren and Schwartz, 2000) .
All precipitated GTPases detected by immunoblot were normalized to GTPase levels detected in membrane fractions.
Rac1-GTP measurements from endogenous Rac1 in HeLa cells or stably BGINexpressing HeLa cell lines were performed as described above, where Rac1-GTP or total Rac1 was measured by immunoblotting with the 23A8 Rac1 antibody. Rac1-GTP measurements from HeLa membrane fractions required generation of a minimum of 1mg of detergent-soluble membranes from two 150mm tissue culture dishes for PBD measurements. Rac1-GTP measurements from SH-SY5Y cells were performed as described above, but required a higher GST-PBD concentration (120 to 150µg of GST-PBD, compared to ~ 30 to 50µg used for assay in HeLa/HEK293T cells).
For all membrane Rac1-GTP, Cdc42-GTP or RhoA measurements, a portion of cytosol and detergent solubilized membranes were immunoblotted for cytosolic/membrane markers and Rac1/myc-Rac1.
Cell fractionation.
Cell fractionation was performed as previously described with some modification . To separate cytosolic, detergent-soluble membranes, and high-molecular weight detergent-insoluble compounds from cultured cells, cells were scraped in fractionation buffer (100mM Pipes, pH 7.3, 100mM KCl, 3.5mM MgCl 2 , 3mM NaCl), sonicated briefly and cleared at 5K x g for 10 minutes. Lysates were then centrifuged at 55K rpm for 1h at 4°C, and cytosolic fractions were removed. Pellets were washed in fractionation buffer and resuspended in fractionation buffer with 1% deoxycholate and Triton X-100, by bath sonication. Samples were subjected to ultracentrifugation (45K rpm, 1h) and detergent-soluble and insoluble fractions were obtained. For separation of cytosolic/membrane fractions only, cells were processed as described above (with the exception of the clearing lysates at 12K x g), membrane pellets were washed once after ultracentrifugation and resuspended by pipetting and bath sonication in fractionation buffer containing 1% NP40). Human brain tissue was subjected to fractionation and analysis in a similar manner, and described in detail in below.
Quality of separation between membranes and cytosolic components was determined by immunoblotting for ERK1/2 (cytosolic) and EGFR or Na+/K+ ATPase (membrane) markers.
Estimating distribution of BGIN-GST domains or BGIN-GFP in cytosol/membrane fractions.
For estimating the abundance of GST constructs expressing full-length BGIN or BGIN BAR, GAP or CIN exon 2 domains ( Figure 4E through 4G), constructs were transfected into HeLa cells and lysates were separated into cytosol and membrane fractions by ultracentrifugation. 30µgs of cytosol/membrane from each sample was immunoblotted for GST alongside a standard curve comprising increasing amounts of purified recombinant GST. The band intensity of the recombinant GST was used to form a linear correlation, and ng quantities of the BGIN-GST fragments were estimated by plotting relative band densities along a y = mx + b linear gradient. The ng GST protein quantities were adjusted for differences in molecular weight relative to GST, and the % of GST protein was calculated from the total protein cytosol/membrane yield. The percentage of protein in membrane fractions were then calculated as a ratio of GST in membrane fractions divided by the total protein expressed in cytosol + membrane in combination.
Estimation of BGIN-GFP abundance in cytosolic, detergent-soluble membranes and detergent-insoluble fractions ( Figure S4A ) was performed similarly by transfecting
HeLa cells with BGIN-GFP constructs with or without MG132 treatment (5µM for 5h),
where biochemical cytosol, membrane and insoluble fractions were generated as described above. 10µg from each fraction was immunoblotted with a linear gradient of recombinant GFP, and the relative percentage of BGIN segregating to each fraction was calculated according to the total protein yield of each fraction.
Mutant CIN exon 2 library screen for non-poly-Ub binding alleles.
A random mutant library comprising the BGIN C-terminal CIN exon 2 domain (BGIN ) was generated using the Diversity (Clontech, Mountain View CA) errorprone PCR system. Reaction conditions producing maximum mutagenic yield (640µM MnSO 4 /200µM dGTP) were used to generate a range between 1 to 15 mutations within the BGIN C-terminal domain. BamH1/Xho1 overhangs from these fragments were cloned into BamH1/Xho1 sites in the pRK5mycGST vector. In order to reintegrate mutant alleles into full-length BGIN constructs, G575 and S576 residues were converted into a unique BamH1 (5' GGATCC 3') site, and mutant allele cassettes were inserted using the recombinant BamH1 site.
184 mutant allele pRK5mycGST constructs were individually transfected into HeLa cells, and GST-CIN exon 2 was precipitated using glutathione sepharose and assayed for poly-Ub coprecipitation by immunoblotting. 45 alleles were identified to uncouple CIN exon 2/poly-Ub interactions, and upon sequence analysis, 37 of these clones comprised frameshift or non-sense mutations, leaving 8 allelelic CIN exon 2 variants comprised exclusively of missense mutations ( Figure S4B and S4C).
Cell spreading on fibronectin
HeLa cells stably expressing BGIN or the mut159 BGIN allele, or cells transiently transfected with GFP or GFP-tagged Q61L Rac1 were suspended and dropped onto glass coverslips coated with 0.0001% fibronectin for 45 mins. Cells were then fixed with paraformaldehyde and co-stained with paxillin antibodies (BD Biosciences) or phalloidin.
Cell area was measured in GFP-positive cells using Metamorph morphometric analysis software in X cells from 3 experiments.
Chemiluminescence measurement of ROS generation
Measurement of ROS by the Nox1 (NADPH oxidase 1) complex in a reconstituted HEK293T cell system was assayed as described previously with some modification (Gianni et al., 2008; Kim et al., 2007) . HEK293T cells were grown to 80% confluency in 6-well plates, and transfected with pRK5myc-Nox1, NoxA1 and Nox01 prior to luminometer reading. The remainder of the cell suspension was pelleted, lysed in buffer with 1% NP40 (20mM Hepes pH 7.5, 150mM NaCl, 10mM MgCl 2 , 5% glycerol) and subjected to immunoblotting. Kinetic measurements were taken for the time indicated at room temperature, and data output was generated in an Excel spreadsheet for analysis.
Endogenous ROS measurement of SHSY5Y cells was essentially undertaken as above, with some modification. Briefly, SHSY5Y cells in 6-well plates were incubated in 0.5mls of trypsin/EDTA for 5 mins. at 37°C, and harvested into 2ml tubes containing 1ml of 1 x DMEM media (complete with 8% FBS). Cells were then processed for chemiluminescence assay as described above. Stably-expressing SHSY5Y cells (APP or BGIN) were seeded at a density of 2.5 x 10 5 cells in 6-well plates one day prior to assay.
Human Brain Samples.
We also thank the patients and their families who provided tissue samples to the 
Fractionation and analysis of human brain tissue
Frozen human brain tissue (250mg) from the frontal cortex was resuspended in 850µls modified fractionation buffer (100mM Pipes, pH 7.3, 100mM KCl, 10mM MgCl 2 , 3mM NaCl) and sonicated for 35 seconds. Debris was cleared by centrifugation (12K x g, 10 mins. at 4°C) and a portion of the lysates were subjected to PBD pulldown assay (500µg) or immunoblotting (30µg). Total lysates were pelleted by ultracentrifugation at 50K x rpm for 50 mins. at 4°C, cytosolic extracts were obtained (and subjected to PBD pulldown assay/immunoblotting) and the pellet was washed once in fractionation buffer.
High-speed pellets were resuspended in fractionation buffer containing 1% triton X-100/1% deoxycholate by bath sonication, and subjected to ultracentrifugation at 50K x rpm for 50mins. at 4°C. Detergent soluble membranes were obtained, and samples were subjected to PBD pulldown assay (250µg protein) or immunoblotting. Pellets were washed, and detergent insoluble fractions were resuspended in fractionation buffer in 1%NP40 by bath sonication.
Transgenic APP mouse strains
APP transgenic mice expressing mutated (Swedish K670M/N671L, London V717I) human(h) APP751 under the control of the mThy-1 promoter (mThy1-hAPP751) (line 41) (Rockenstein et al., 2001) were used. We have previously shown that these mice display loss of synaptic contacts, high levels of A 1-42 production, early amyloid
